Loading data
AGCONYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 10.08 bn USD | 11.66 bn USD | 14.41 bn USD | 12.65 bn USD | 11.14 bn USD |
| Cost of revenue | 7.52 bn USD | 8.76 bn USD | 10.64 bn USD | 9.65 bn USD | 8.57 bn USD |
| Gross profit | 2.57 bn USD | 2.9 bn USD | 3.78 bn USD | 3 bn USD | 2.57 bn USD |
| Research and development expense | 374.5 m USD | 381.3 m USD | 420.9 m USD | 315.4 m USD | 272.9 m USD |
| Selling, general and administrative expense | 1.31 bn USD | 1.4 bn USD | 1.45 bn USD | 1.19 bn USD | 1.09 bn USD |
| Operating profit | 595.7 m USD | -122.1 m USD | 1.7 bn USD | 1.27 bn USD | 1 bn USD |
| Interest expense | — | — | 68.8 m USD | 46 m USD | 25.4 m USD |
| Income tax expense | -77.4 m USD | 98.4 m USD | 230.4 m USD | 296.6 m USD | 108.4 m USD |
| Net income (reported basis) | 719 m USD | -485.6 m USD | 1.17 bn USD | 874.7 m USD | 901.5 m USD |
| Basic earnings per share | 9.76 USD/share | -5.69 USD/share | 15.66 USD/share | 11.92 USD/share | 11.93 USD/share |
| Diluted earnings per share | 9.75 USD/share | -5.69 USD/share | 15.63 USD/share | 11.87 USD/share | 11.85 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.